• Eat Well Investment Group Inc. is a brand builder and investor in plant-based consumer products, many of which have already established their popularity and function in North American markets
• The company’s investments in 2021 have led to growing revenues, and company officers forecast continuing to grow to about $100 million in sales by the end of 2022
• Eat Well Investment’s majority-owned Amara toddler organic food line was named Amazon’s top new release last year
• The company’s products enjoy a place on big box retail store shelves such as Walmart, Whole Foods, and Sprouts Farmer’s Market, and in January Eat Well announced they are also available nationwide across Canada in Loblaws Inc. stores

As the worldwide COVID-19 pandemic enters its third year, plant-based foods investment company Eat Well Investment Group (CSE: EWG) (OTC: EWGFF) is celebrating the stability of its holdings’ international sales and its prospects for revenue growth during the coming year. Eat Well Investment Group has built its vertically integrated approach to feeding people delicious, more nutritious food at a lower cost than market standard and with greater accessibility at a global scale since turning its focus from providing venture capital funding for early-stage companies, to acquiring companies outright or acquiring majority stakes in companies. The company’s primary aim is to create “transformational opportunities at scale within the plant-based agribusiness (pulse protein) and emergent foodtech CPG space” thanks to an experienced cadre of personnel, and a consumer product line that boasts “proteins, starches, and fiber (that) are now common ingredients in many everyday CPG products (not just vegan), from crackers, snacks, pastas, breads, plant-based meats, and milks/beverages” (https://ibn.fm/nXIB6). After completing acquisition of plant-based food companies Belle Pulses and Sapientia Technology LLC on July 31, Belle Pulses-related revenues had increased more than 35 percent YOY as of the company’s most recent quarterly financials filing, according to the company’s statement. Sapientia launched its first commercial product — plant-based twisted curls snacks created by the company’s founder and president, who invented the highly successful Twisted Cheetos — in December. Eat Well Group plans to scale its new revenue channel during the coming year with additional product offerings (https://ibn.fm/TTPPH). Eat Well’s efforts to promote nutritional health through quality products under its banner also include its agreement in October to acquire a 51 percent initial investment in Pata Foods Inc., which is doing business as healthy and affordable baby and children’s food company Amara. Amara Organic Foods’ toddler line had grown its revenue five times (533 percent) between January 2021 and January 2022, and had the distinction of being named e-commerce giant Amazon’s top new release (https://ibn.fm/diCuz). Amara also enjoys a strong retail footprint through big-box retailers that include Walmart, Whole Foods and Sprouts Farmer’s Market, and as of January, nationwide across Canada in Loblaws Inc. Eat Well has an option to acquire additional ownership in Amara up to 80 percent. As of Dec. 21, the company’s officers stated they expected company revenues to reach $60 million by the end of 2021 and that they are forecasting about $100 million in revenue for 2022. Food security has become a growing concern worldwide amid concerns about climate change, and efforts to diversify agribusiness offerings and focus on climate-friendly food sources such as plant-based products have increased (https://ibn.fm/bKIoO). For more information, visit the company’s website at www.EatWellGroup.com. NOTE TO INVESTORS: The latest news and updates relating to EWGFF are available in the company’s newsroom at https://ibn.fm/EWGFF

• LQwD is the first publicly traded Lightning Network company
• In November 2021, LQwD launched its proprietary SaaS lqwd.tech, a Lightning Network software platform to lower transaction fees, more efficient liquidity, and seamless use of the global payments’ infrastructure
• The platform also helps complete transactions with lower wait times
• Since January 21, 2021, the Lightning Network has seen over 100% growth in multiple areas of development

LQwD FinTech (TSX.V: LQWD) (OTCQB: LQWDF), a Bitcoin Lightning Network company focusing on the development of institutional-grade payment infrastructure and solutions, has provided a corporate recap covering major highlights since the acquisition of LQwD took place in June 2021 and the creation of the first publicly traded Lightning Network company (https://ibn.fm/QdSVR). “I wanted to take a moment to recap what has been an active six months for LQwD since listing in June,” LQwD CEO Shone Anstey stated. “The remarkable growth of the Lightning Network has validated LQwD’s reason to be hyper-focused on Lightning, and I look forward to continuing to expand our business on this rapidly growing global payment network.” The Lightning Network is a layer two payment technology and solution for the scaling of Bitcoin for microtransaction around the world. Additionally, the network provides users the ability to complete transactions at a rate of millions per second, lowers fees, and offers instant settlement times. Since January 2021, the Lightning Network has seen node growth of 105% for node establishment from 770 to over 15,000, increased Bitcoin capacity from 1,125 BTC to almost 3,000 BTC – up 160% to September 30, 2021, and a 92% increase in the number of payment channels, totaling more than 73,000 up from the initial 38,000. Here is a look at the accomplishments that LQwD has seen since June 2021:

• June 9, 2021: completed a non-brokered private placement for proceeds of C$5,000,000 (US$3.99 million);
• October 28, 2021: completed an offering of 23,000,000 units for proceeds of C$8,050,000 (US$6.4 million);
• Cumulatively acquired over C$9,000,000 (US$7.19 million) worth of Bitcoin as an operating asset on the Lightning Network, increasing the company’s holdings to around 150 Bitcoin;
• Launched the company’s proprietary software as a service (SaaS) – the multi-pronged Lightning Network software platform (lqwd.tech) allows B2B markets, investors, and others broader access, more efficient liquidity, and seamless use of the global payments’ infrastructure;
• Entered into two strategic service agreements – one with Netcoins, Inc., a leading Canadian crypto trading platform and subsidiary of BIGG Digital Assets Inc., and the other with Breez Development Ltd., an Israeli-based Lightning Network wallet provider;
• Experts in the industry, Joost Jager and Roy Sheinfeld were named as strategic advisors for the company, and Alexandra Moxin was named VP of Product for the company;
• Participated in the Adopting Bitcoin – A Lightning Summit in El Salvador from November 16-18, which brought together industry leaders and experts to discuss the future of money and payments in the Central America region and abroad.

In September 2021, El Salvador was the first country to adopt Bitcoin as its legal tender. The rise of Bitcoin in El Salvador is primarily due to the lack of access to financial institutions. The country adopted a digital wallet app for residents and consumers at this time as well. A supporter of the change, El Salvadoran President Nayib Bukele explained that converting the legal tender will also help the population access the billion dollars in remittances that those living outside of their homeland send back each year. As Bitcoin continues to grow in in value and popularity, more people, institutions and companies are looking for dedicated services to help them make purchases and transactions using the cryptocurrency. LQwD expects this trend to continue and that the Lightning Network will be a force for change worldwide and become the global monetary exchange of the future. For more information, visit the company’s website at www.LQwDFinTech.com. NOTE TO INVESTORS: The latest news and updates relating to LQWDF are available in the company’s newsroom at https://ibn.fm/LQWDF

Event Highlights:

• Perspectives of payers on diagnostic evidence and access
• Evidence targets for increasing coverage through laboratory benefit management
• Defining diagnostic value relative to costs for payer networks: generating and applying clinical evidence
• Increased need for prior authorizations has an impact.
• Impact of changing health policies on test coverage and reimbursement

Q1 Life Science Regulatory Intelligence Conference brings together specialists from around the world in the fields of global intelligence, strategy, policy, and law to share best practices on regulatory concerns. Examine how your peers inform internal stakeholders about regulatory changes and competitive intelligence, provide feedback on submissions, and comment on new guidance materials. Moving regulatory expectations, creating an internal sharing point site, and a broader look at global concerns, including working with international health authorities, are all highlighted in case studies and group discussions. To optimize retention and involvement, this is a two-day session with multiple breaks. The innovative event platform from Q1 Production provides the ultimate virtual experience. Networking tools that are thoughtfully designed and configurable encourage a sense of cooperation and discussion, allowing attendees to develop direct connections. Why Should You Attend It?

• You’ll gain firsthand insight into current solutions thanks to a unique experience with professional thinking leaders.
• Learn about current subjects directly connected to your sector through lively panel discussions, case studies, and real-world proof.
• We give a forum for your team to ask questions of industry professionals with years of experience. The key to expanding your knowledge and perceiving things in a new light.
• You and your team will have access to insight and interaction. Collaborate with your peers to overcome common difficulties by drawing on their knowledge and expertise.

Some Event Details Regulatory teams also inform internal stakeholders about policy developments and the potential effects on each business function as well as the broader organization, in addition to combing through multiple sources to get essential intelligence. Regulatory intelligence executives create interesting newsletters by integrating important information in a visually appealing manner to keep stakeholders’ attention, and they are sometimes compelled to provide deeper dive reports on more difficult standards, such as EU MDR. All participants will have the opportunity to meet new attendees and connect through engaging conversations, as well as create contacts with peers, during this interactive session, which will kick off the event networking platform. For more information, please visit https://ibn.fm/qWIXU

On February 7-8th, 2022 in Philadelphia, DGE will hold the Investigator Trials Summit, which will provide delegates with the most up-to-date information on the full spectrum of challenges facing the industry:  from reviewing proposals and aligning research with the corporation’s goals, to closing out studies and handling publication data, all while adhering to strict legal and regulatory frameworks on an international playing field. The IIT Summit will feature sessions on the industry’s most pressing issues, such as multi-centered monitoring, assuring ROI, developing a publication strategy, and learning from practical case studies. Guest speakers, including Pfizer’s Alexander Kostek and Actelion Pharmaceuticals’ Joelle Rebetez, will lead in-depth and collaborative sessions as well as interactive panel discussions on a variety of timely issues. The conference will feature a small-group format to encourage greater peer-to-peer networking and promote conversation among industry professionals, as well as customized workshops for pharmaceutical and medical device firms of all sizes. Why Should You Attend?

• Examine the complex regulatory requirements of sponsor-investigator research
• Clarity on the importance of collaborating with key stakeholders to improve IITs
• Advice on how to end a study while keeping the relationship with the investigator intact
• The contrasts between an industry-sponsored study and Collaborative Research are summarized here
• Key strategies for MSLs to effectively collaborate and manage an IIT
• Best methods for including diversity and inclusion in funded studies
• A guide to creating budgets, contracts, and determining fair market value

The conference will bring together clinician scientists, researchers, and professionals from research institutions, policymakers, industry, and regulatory organizations. By addressing current difficulties and showcasing creative solutions, the agenda will provide the groundwork for future success in investigator-initiated studies. For more information, please visit https://dgevents.com/event/investigator-initiated-trials-summit/.

• Artist Republik will join Fan Pass Live as a Friendable company, significantly increasing the number of artists on the platform
• The new acquisition will also bring ample technology and other artist services that will benefit the Fan Pass Live artist pool as well
• CEO and Co-Founder Robert Rositano Jr. explained that one of the company’s main goals has always been to test multiple entry points to gain exposure in the music industry for artists and fans alike

Mobile technology and marketing company Friendable (OTC: FDBL) announced the completion of a significant acquisition and business combination between the company’s flagship product, Fan Pass Live, and iconic music distribution company Artist Republik (https://ibn.fm/DXduT). The announcement marks the official closing of the transaction and confirms that Artist Republik is now officially a Friendable company alongside Fan Pass Live. The acquisition comes after approximately one year of talks and negotiations between the two companies to seal a partnership, as Artist Republik was moving toward the development of livestream services and Fan Pass was moving toward its own music distribution offering, Friendable CEO and Co-Founder, Robert A. Rositano Jr. explained. “As our management teams began to engage more frequently, the opportunity arose to combine our two offerings and truly offer a platform and services that would allow Fan Pass to push the boundaries of our offering in the music industry with a shared philosophy of truly putting the artist first. Our services are designed to elevate each artist, garner new fans, build awareness and exposure, and, most of all, build revenue that the artist keeps, rather than paying back debt created by label advances,” Rositano Jr. added. The acquisition will allow Fan Pass Live the opportunity to leverage existing, new, and acquired technology, along with current resources, to further increase historical and ongoing revenue achieved by Artist Republik so far. The acquisition will also solidify the platform’s existing suite of products and services already in place to empower artists (with a focus on independent artists) to gain more control over their music – giving Fan Pass Live an all-inclusive artist offering. “Additionally, the Artist Republik brand has received numerous accolades from trade and industry publications such as Billboard and Forbes magazines, which align perfectly with the press efforts of our current team at Lobeline Communications as they continue to spread the word about our brand to artists and the entertainment trade press in general,” the Friendable CEO added. The new partnership will add approximately 100,000 active music artists and various music distribution services, thus tripling Friendable’s technology assets. Together, Fan Pass Live and Artist Republik will offer a suite of artist-centric services aimed at extending livestream capabilities and virtual performance options. Fans will now be able to enjoy access to a variety of artists across multiple genres, participate in exclusive live events, gain access to behind-the-scenes content, purchase artist-specific merchandise, and more. Artists will also receive more autonomy and freedom over their music, ticketed streams, blog/social promotions, developing their exclusive merchandise, sales, and more. All of this is available to artists without the requirement to give up their musical rights. According to Rositano Jr., Friendable was also able to retain the Artist Republik CEO and CTO as initial consultants after the acquisition, assisting with integration efforts and expanding the service offering. The Friendable CEO underlined that this acquisition aligns with his company’s strategy to test multiple entry points or ‘doors’ that lead artists and fans to discover the Fan Pass Live offering. “Whether they come in through the music distribution door which leads to livestream service consumption or artists coming through the livestream, end up consuming music distribution services, our platform has come full circle,” he said. “We look forward to expanding the Fan Pass Live artist and fan community through this initial acquisition, and we plan to set the stage for additional acquisition opportunities alongside dynamic partnerships that will continue to fuel our growth.” For more information, visit the company’s websites at www.Friendable.com or www.FanPassLive.com. NOTE TO INVESTORS: The latest news and updates relating to FDBL are available in the company’s newsroom at http://ibn.fm/FDBL

• 2021 marked the year when FingerMotion invested heavily into its insurtech product and service offering
• It forged partnerships with key players such as Pacific Life, Happy Life Insurance, and Munich Re to further develop innovative insurance business models for its customers
• These investments would see a 48% year-over-year growth in the number of insurtech business deals for the company from 2020
• FingerMotion hopes that these investments, coupled with its strengthened position as a mobile data service provider, will help it to grow its customer numbers to over a billion

FingerMotion (NASDAQ: FNGR), since its inception, has always pushed the envelope with innovation. This commitment has made it a key player in the Chinese market, particularly with its mobile payment and recharge platform solutions. Its tech innovations have also trickled down to the insurtech sector, in which FingerMotion is a critical player. For the 2021 calendar year, FingerMotion stamped its position as an industry leader in the mobile data service sector. Its innovations benefitted hundreds of thousands of users while also laying down the foundation for further expansion to serve over a billion users in China and neighboring regional markets. FingerMotion kicked off the year with the qualification to trade on the OTCQX Best Market, an upgrade from the OTCQB. The move would see the company gain greater access to the capital markets while also offering it an opportunity to be more transparent to institutional investors who rely on the more rigorous review of the company (https://ibn.fm/zGtFv). Even with the OTCQX listing, the insurance sector was one of the primary beneficiaries of FingerMotion’s 2021 growth and expansion plan. At the beginning of the year, the company entered into a services agreement with Pacific Life Re through its big data analytic arm, Sapientus. Pacific Life, a global life reinsurer, would help FingerMotion develop a holistic multi-faceted risk rating concept, allowing it to draw data from novel sources and filter them through advanced algorithms for better service delivery (https://ibn.fm/kB1Of). Later in the year, FingerMotion would collaborate with other enterprises, including Happy Life Insurance and Munich Re, to develop innovative insurance business models powered by data and specifically designed to deliver a suite of digital insurance solutions for consumers. By the end of the year, the company had already achieved a 48% year-over-year growth in the number of insurtech business deals (https://ibn.fm/81SIR). Going into 2022, the company anticipates operationalizing its latest insurtech services. It hopes that this will play an integral role in the further growth of the enterprise and in achieving its objective of serving over a billion users in the region. Additionally, it plans to take advantage of its listing on the NASDAQ Capital Market, even as it strengthens its position as a mobile data service provider for the Chinese market. Through outstanding leadership over the 2021 calendar year, FingerMotion has forged integral strategic partnerships with key players in specific industries within China. In addition, the company has also invested a lot into the technology, products, and services that it offers. Combined, these moves have allowed it to position itself as a key player within the mobile data services sector and the Chinese insurtech space. The global insurtech industry is projected to grow by $33.7 billion between 2021 and 2025, representing a Compound Annual Growth Rate (“CAGR”) of 45.28% over the forecast period (https://ibn.fm/patr9). FingerMotion is positioning itself to take advantage of this growth. For more information, visit the company’s website at www.FingerMotion.com. NOTE TO INVESTORS: The latest news and updates relating to FNGR are available in the company’s newsroom at https://ibn.fm/FNGR

• Lexaria has multiple studies planned that will commence early in 2022
• DehydraTECH increases Lexaria’s ability to leverage multiple markets, including the growing CBD sector, which is expected to meet and exceed $108 billion in revenue by 2027
• DehydraTECH can increase the efficacy of the drugs being administered, offering faster absorption and lowering the delivery time

In a strategic move to start off 2022, Lexaria Bioscience (NASDAQ: LEXX), a global innovator of drug delivery platforms, has announced that it has signed an advertising and media contract with financial technology company SRAX (NASDAQ: SRAX). The contract will facilitate media buys and digital marketing by SRAX on behalf of Lexaria. This announcement is only the beginning of what the company anticipates to be the busiest year yet. Chris Bunka, CEO of Lexaria, was more than pleased with the contract signed and with SRAX, and he voiced optimism about the year-long campaign that has commenced and its outcomes. “Lexaria has made tremendous progress during 2021, and we expect even more significant advancement in 2022 and are pursuing the broadest possible investor involvement to ensure that Lexaria’s achievements are communicated to all investors,” Bunka added (https://ibn.fm/aASrd). Lexaria’s patented DehydraTECH(TM) was designed for orally delivered fat-soluble drugs and other active pharmaceutical ingredients and this technology has shown it increases effectiveness and improves absorption into the bloodstream. Through this technology, Lexaria demonstrates many benefits:  efficiently reduces delivery time to bloodstream and thus shortens the time it takes for these drugs to take effect; increases brain absorption; reduces the costs required for drug administration through smaller doses; increases the level of drug in the bloodstream for greater effectiveness; and masks the unpleasant tastes of many oral drugs. After the progress that Lexaria made in 2021, the company has several projects lined up to be initiated and conducted throughout the new year. Lexaria already has planned:

• A human clinical trial over the duration of six weeks to study hypertension and how Lexaria’s DehydraTECH-CBD (cannabidiol) may provide potential hypertension relief
• An oral nicotine human study (which may be industry-changing) that includes subjective and objective parameters to demonstrate the superiority of DehydraTECH-nicotine as compared to the industry’s leading product
• Animal studies that are designed to determine if DehydraTECH-CBD can provide seizure relief and compare it against the current FDA-approved pharmaceutical regimen for treatment against seizures
• Completion of the company’s pre-IND meeting with FDA so that they may proceed with the IND application process – registering the clinical trial testing that will be conducted with DehydraTECH-CBD for hypertension relief

Lexaria has the potential to leverage more than one expanding pharmaceutical market using the company’s patented DehydraTECH technology. These markets include but are not limited to  CBD, oral nicotine, and other fat-soluble molecularly structured drugs. The CBD market alone is rapidly growing, providing multiple opportunities for innovation and investment. The market was worth over $7.1 billion in 2020 and is expected to grow at a CAGR of 35% to exceed $108 billion by 2027 (https://ibn.fm/v2d5w). The drivers for growth in this industry include the rising interest in medical applications using CBD, product adoption and utilization with government approval, the continually changing regulatory landscape for CBD products, and the increase of retail sales. Lexaria is a global leader in CBD research. Another market Lexaria has the potential to tap into is the global antihypertensive therapeutics sector. According to Allied Market Research, the global antihypertensive drugs market accounted for $22,557 million in 2018, and is expected to reach $28,797 million by 2026, expanding at a CAGR of 3.1% (https://ibn.fm/lDt5j). For more information, visit the company’s website at www.LexariaBioscience.com. NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

• Information overload occurs when the amount of input to a system exceeds its processing capacity
• Managing information in daily life is a problem facing nearly everyone
• Pluaris is a proprietary, easy-to-use platform that assists users with reading and analyzing textual data

Although the term “information overload” was first coined more than five decades ago, it’s become a more pressing issue with time. Nowigence Inc. (NOWG) is working to solve the issue. A fast-growing SaaS (Software-as-a-Service) company, Nowigence has developed an innovative, artificial intelligence (“AI”) platform called Pluaris(TM) that enables users to choose what information they want to receive and then delivers that information most effectively. “The term ‘information overload’ was coined by Bertram Gross, the professor of political science at Hunter College, in his 1964 work, ‘The Managing of Organizations’,” reported a recent Interaction Design Foundation article (https://ibn.fm/QkVXD). “However, it was popularized by Alvin Toffler, the American writer and futurist, in his book ‘Future Shock’ in 1970. “Gross defined information overload as follows: ‘Information overload occurs when the amount of input to a system exceeds its processing capacity. Decision makers have fairly limited cognitive processing capacity. Consequently, when information overload occurs, it is likely that a reduction in decision quality will occur,’” the article continued. “Throughout history there have been complaints about information overload particularly during the Renaissance and the industrial revolution periods. However, the dawn of the information age and access to powerful and low-cost data collection on automated basis has brought us more information than at any other point in history.” The article observes that “managing information in daily life is no longer restricted to a wealthy elite but is a problem which faces nearly everyone. Social media, e-mail, webpages, mobile apps, etc. all spill data into our lives daily.” The article noted that the most common reasons behind information overload in today’s modern world include volumes of new information being constantly created and distributed, as well as the ability to easily duplicate and share that information. The exponential increase in channels has also contributed to the problem. In addition, the article noted that there are no simple methodologies for quickly processing, comparing and evaluating information sources. Enter Nowigence’s Pluaris. Pluaris is a proprietary, easy-to-use platform that assists users with reading and analyzing textual data (https://ibn.fm/KkJwH). The platform is for those who want to automate the way they read, gather, learn and recall information. Each feature of Pluaris is designed to accelerate the way we learn and improves the process for sharing knowledge with one another. Pluaris generates an annotated data feed based on specified topics of interest and then automatically creates a permanent personal knowledge base from a user’s feed and private uploads. The app has human-like capabilities for comprehending textual data and providing concise summaries and precise answers to questions, while also analyzing different data perspectives, discovering new connections, creating organized, nested notes and allowing teams to work together by sharing in real time from anywhere in the world. Nowigence is focused on simplifying the challenges of learning. By integrating state-of-the-art data processing techniques in an intuitive interface at an affordable subscription price, Pluaris puts the power of data science into the hands of consumers. For more information, visit the company’s website at www.Nowigence.com. NOTE TO INVESTORS: The latest news and updates relating to Nowigence are available in the company’s newsroom at https://ibn.fm/NOW

• PlantX is celebrating the debut of its XMarket Café at the Rideau Hudson’s Bay in Ottawa
• The café will feature carefully curated plant-based foods and vegan beverages
• The company has also opened the signature XMarket stores inside the Hudson Bay locations in Yorkdale Mall in Toronto and Rideau Mall in Ottawa
• The stores will offer a curated selection of plant-based products across different segments
• The Rideau XMarket store will also help PlantX with its distribution to online customers

In furthering its commitment to expand its reach to a wider audience in order to make plant-based foods more accessible, PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) has opened XMarket Café at the Rideau Hudson’s Bay in Ottawa, along with the signature XMarket shops inside the Hudson Bay at the Rideau Mall in Ottawa and Yorkdale Mall in Toronto (https://ibn.fm/aNoTL). The 100% plant-based café will feature carefully crafted vegan beverages and delicious plant-based menu items for breakfast, lunch, and dinner, curated by chefs and colleagues under the Matthew Kenney Cuisine umbrella. Shoppers at the Rideau XMarket store will be delighted with plant-based food offerings and beverages every day of the week from 11 am to 7 pm. PlantX will also support Ottawa businesses by sourcing the café’s ingredients locally. Meanwhile, the newly opened XMarket stores, which extend PlantX’s partnership with Hudson’s Bay that began when PlantX launched as a seller on TheBay.com in April 2021 (https://ibn.fm/SrlZD), will offer a curated assortment of plant-based personal care, home, grocery, pet, and grocery products. “Having a retail space in Hudson’s Bay’s locations offers incredible opportunities to exert our plant-based impact and build on our retail efforts. We’re thrilled to have physical spaces within Ottawa and Toronto communities to offer a more direct and dynamic PlantX experience,” commented PlantX Founder Sean Dollinger. The Rideau XMarket shop will also help PlantX with its order fulfillment and distribution for its online customers located in Canada’s east coast, including shoppers on TheBay.com Marketplace, facilitating same-day PlantX deliveries in the Ottawa locality. Similarly, it will accelerate the shipping of PlantX products across the rest of Canada. The distribution capacity and capabilities offered by the Rideau XMarket shop bodes well for PlantX’s immediate growth plans. During a December EDGE Podcast interview hosted by Entrepreneur and Angel Investor Brandon C. White, PlantX President and CEO Lorne Rapkin intimated that the company intends to focus on groceries as the next phase of growth (https://ibn.fm/sAWko). “We are going to see a lot of growth in groceries. So as much as [PlantX] is going to be an e-commerce/brick-and-mortar offering, which is what we are doing by building out the stores and attracting future franchisees, groceries are really where we are taking the company… Our brick-and-mortar stores will be a good centralized hub, but we are investing in warehousing,” Lorne noted. PlantX’s new fulfillment centers will help it achieve more real-time, efficient deliveries as well as improved customer experiences. Already, the company has strategically secured warehouses in both Canada and the United States. The investment in launching new XMarket physical locations, PlantX believes, will distinguish its operations from the competition by ensuring fast deliveries of bought products. At the same time, PlantX is positioning its existing brick-and-mortar XMarket stores in Venice, California and Hillcrest, San Diego, the newly opened shops in Rideau and Yorkdale, and the planned Tel Aviv, Israel shop as flagship stores that will help potential franchisees learn about the intricacies and viability of the business in order to later open additional XMarket stores under a franchising model. XMarket emerged following a partnership and acquisition between Chef Matthew Kenney of the Matthew Kenney Cuisine and PlantX. On its part, PlantX acquired Kenney’s vegan marketplace, New Deli, in 2019 and subsequently took over the Venice, California New Deli location in April 2020, relaunching it as XMarket (https://ibn.fm/HmZNk). Since then, the company has grown its XMarket brand significantly by opening stores in multiple localities in Canada and the United States, with plans to launch more. For more information, visit the company’s websites at www.PlantX.com, www.PlantX.ca, and https://investor.plantx.com/ and view PlantX for Plant-Based Investors. NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at https://ibn.fm/PLTXF

• RWB recently reported its Q3 2021 financial results in which revenues grew 93% YOY
• The company is pursuing vertical integration in multiple states, including Florida, California, and Michigan
• In Florida, RWB has launched cultivation operations and a processing facility expected to provide additional inventory for its Springhill dispensary, as well as three new dispensaries set to be opened in Q1 2022
• According to RWB Chairman and CEO Brad Rogers, vertical integration will help drive increased revenue and margins for the company

In the third quarter of fiscal 2021, multistate cannabis operator and house of premium brands Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) made excellent progress that reflected in financials captured in a November 30 news release. The announcement, which highlighted the company’s 93% year-over-year revenue growth from $6.1 million in Q3 2020 to $11.8 million in the most recent quarter, also provided additional details on the RWB’s prospects and strategic plans, one of which is vertical integration (https://ibn.fm/6fiK5). “In the third quarter, we made excellent progress in laying additional building blocks in our core operating states of Florida, Michigan, and California to become more vertically integrated where it will be most profitable,” commented RWB Chairman & CEO Brad Rogers as part of the announcement. “This will help drive increased revenue and margins for the company.” In Florida, RWB’s operations include active cannabis cultivation sites, an operational processing facility, and a dispensary. Through its Red White & Bloom Florida LLC (“RWBFL”) subsidiary, RWB commenced cultivation at its Apopka, Florida greenhouse site in late September, following the receipt of regulatory approval (https://ibn.fm/g8Svz). Later, in October, the company received OMMU approval of five of 30 growing pods, sanctioning the loading and growing of high-quality flower. RWB also has a 113,000-square-foot indoor growing facility in Sanderson, Florida, that it intends to operationalize soon as part of a three-phase Florida expansion plan. In terms of processing capabilities, RWBFL completed the build-out of a new production facility in Sanderson in early September to accommodate the fast-growing demand for edibles in the Florida market. And in early November, the company reported the production of the now-operational facility’s first batch of chocolates. “Coupled with our cultivation and processing in Sanderson, the additional product [from the growing pods] will ensure Red White & Bloom has the needed inventory to fulfill inventory requirements at our HighTimes (“HT”) Medical Cannabis dispensary in Springhill and for the next three dispensaries opening in the first quarter of 2022. The locations of the three dispensaries are St. Petersburg, Daytona, and Miami Beach,” commented Rogers in a November 4 news release (https://ibn.fm/XWW4a). In addition to its expanding retail footprint, RWB also holds exclusive HT naming rights for all retail dispensaries in Michigan, Illinois, and Florida (https://ibn.fm/b2Fan). In Michigan, RWB expects to be vertically integrated upon closing a pending acquisition of an investee whose Michigan facilities include active and planned dispensaries, cultivation sites, and company-owned real estate holdings. “RWB is being very strategic in pursuing vertical integration only when there is value to be added. We aim to be asset-light and brand-rich. Our strategy is to support the brands in the most profitable way,” commented RWB CFO Chris Ecken. “As RWB integrates vertically in multiple states, we anticipate that our margins will dramatically increase, enabling us to move toward profitability.” For more information, visit the company’s website at www.RedWhiteBloom.com. NOTE TO INVESTORS: The latest news and updates relating to RWBYF are available in the company’s newsroom at https://ibn.fm/RWBYF